Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease-Reference-Cited by-同舟云学术

Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease

Published:2019 Issue:4 Volume:10 Page:684
ISSN:2152-5250
Container-title:Aging and disease
language:en
Short-container-title:Aging and disease

Author:

Maeso-Díaz Raquel,Ortega-Ribera Martí,Lafoz Erica,Lozano Juan José,Baiges Anna,Francés Rubén,Albillos Agustín,Peralta Carmen,García-Pagán Juan Carlos,Bosch Jaime,Cogger Victoria C,Gracia-Sancho Jordi

Publisher

Aging and Disease

Subject

Cell Biology,Clinical Neurology,Geriatrics and Gerontology,Pathology and Forensic Medicine

Link

http://www.aginganddisease.org/fileup/2152-5250/PDF/ad-0-0-0-1902181946-1.pdf

Reference47 articles.

1. He W, Goodkind D, Kowal P (2016). An Aging World: 2015 International Population Reports. US Gov Publ Off Washington, DC P95/16-1.

2. Le Couteur DG, McLean AJ (1998). The aging liver: Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet, 34: 359-373.

3. Maeso-Díaz R, Ortega-Ribera M, Fernández-Iglesias A, Hide D, Muñoz L, Hessheimer AJ, et al. (2018). Effects of aging on liver microcirculatory function and sinusoidal phenotype. Aging Cell, 17: e12829.

4. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (2013). The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol, 58: 593-608.

5. Marcellin P, Kutala BK (2018). Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int, 38: 2-6.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deacetylation of HnRNP U mediated by sirtuin1 ameliorates aged rat with liver fibrosis via inhibiting p53-related senescence and NLRP3-related inflammation;International Immunopharmacology;2024-11

2. Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: Integrating network pharmacology and RNA sequencing via in silico and in vitro studies;Phytomedicine;2024-10

3. Investigating the correlation between polyunsaturated fatty acids intake and non-invasive biomarkers of liver fibrosis;Clinical Nutrition ESPEN;2024-10

4. The Pathophysiology of Portal Hypertension;Clinics in Liver Disease;2024-08

5. Pathophysiology and therapeutic options for cirrhotic portal hypertension;The Lancet Gastroenterology & Hepatology;2024-07